Zoetis (ZTS) Research & Development (2012 - 2026)

Zoetis' (ZTS) quarterly Research & Development came in at $180.0 million in Q1 2026, up 11.11% year-on-year from $162.0 million in Q1 2025, and down 9.55% on a QoQ basis from $199.0 million in Q4 2025.

Zoetis (ZTS) Research & Development (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 13 years of Research & Development data on file, last reported at $180.0 million in Q1 2026.

  • On a quarterly basis, Research & Development rose 11.11% year-over-year to $180.0 million in Q1 2026; TTM through Mar 2026 was $721.0 million, a 5.1% increase from a year earlier, with the FY2025 full-year figure at $698.0 million, up 1.75% from the prior year.
  • Research & Development for Q1 2026 stood at $180.0 million, down from $199.0 million in the prior quarter.
  • Over the last five years, Research & Development for ZTS reached as high as $199.0 million in Q4 2025 and fell as low as $122.0 million in Q1 2022.
  • Historically, Research & Development has averaged $160.1 million across 5 years, with a median of $162.0 million in 2024.
  • Across the five-year window, Research & Development rose 17.57% in 2023 and changed 0.0% in 2025, its largest moves.
  • Year by year, Research & Development stood at $148.0 million in 2022, then gained by 17.57% to $174.0 million in 2023, then grew by 6.9% to $186.0 million in 2024, then climbed by 6.99% to $199.0 million in 2025, then slipped by 9.55% to $180.0 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $180.0 million in Q1 2026, $199.0 million in Q4 2025, and $170.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 138.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 97.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 180.00 Mn
Dec 31, 2025 199.00 Mn
Sep 30, 2025 170.00 Mn
Jun 30, 2025 172.00 Mn
Mar 31, 2025 162.00 Mn
Dec 31, 2024 186.00 Mn
Sep 30, 2024 167.00 Mn
Jun 30, 2024 171.00 Mn
Mar 31, 2024 162.00 Mn
Dec 31, 2023 174.00 Mn
Sep 30, 2023 152.00 Mn
Jun 30, 2023 146.00 Mn
Mar 31, 2023 142.00 Mn
Dec 31, 2022 148.00 Mn
Sep 30, 2022 134.00 Mn
Jun 30, 2022 135.00 Mn
Mar 31, 2022 122.00 Mn
Dec 31, 2021 138.00 Mn
Sep 30, 2021 132.00 Mn
Jun 30, 2021 120.00 Mn